Data analysis showed that 40% of patients who filled a prescription for Wegovy in 2021 or 2022 were still taking it a year later; both Democrats and reproductive rights organizations are pressuring the Biden administration to ensure health insurers fully cover contraception; CMS implemented Medicare changes in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy.
An analysis of medical records and insurance claims data showed that 40% of patients who filled a prescription for semaglutide (Wegovy) to treat obesity in 2021 or 2022 were still taking it a year later, according to Reuters. This adherence rate was more than 3 times that of older weight loss drugs. For example, only 13% of patients taking naltrexone/bupropion (Contrave) and only 10% of those who started phentermine/topiramate (Qsymia) between 2015 and 2022 were still filling their prescriptions a year later. The researchers also found persistence at 1 year to be associated with greater weight loss at 6 months. Conversely, they found adherence rates within privately insured patients varied by insurance carrier due to coverage limitations and certain pre-certification criteria, like step therapy. Consequently, concerns have been raised over the high costs and non-persistence associated with weight loss drugs as this could inform third-party payers' coverage decisions.
Both Democrats and reproductive rights organizations are reinforcing their pressure on the Biden administration to ensure health insurers fully cover contraception, according to Axios. Under the Affordable Care Act (ACA), most insurers are required to cover at least 1 form of each FDA-approved contraception method at no cost. Groups are claiming that companies are failing to meet the ACA requirement, with evidence that some insurers are improperly charging women or denying coverage of some birth control methods. More specifically, last month, members of Vermont’s Democratic congressional delegation called on the Biden administration to enforce mandated birth control coverage, as a state investigation found that over 9000 patients were wrongly charged for contraceptive costs. Vermont was not the first state to report insurance denials, causing the Biden administration to remind insurers of their coverage obligations last year and look at new ways of expanding birth control access.
CMS implemented changes to Medicare in March that limited access to blood tests that help transplant recipients ensure their organs remain healthy, according to USA Today. CMS said in a statement that Medicare administrative contractors discovered improper billing and overuse of the tests. As a result, CMS updated billing and coding to limit who can administer the tests for the MolDX molecular testing program and where. Medical experts and patient advocates explained that the Medicare change limited patient access, putting them at immediate risk, particularly those who are low-income or people of color who already face existing barriers to care. On Tuesday, a bipartisan group of lawmakers planned to call on the Biden administration to reverse the change, especially due to the recent law streamlining a waitlist of more than 100,000 people waiting for organ transplants. These patients will all need testing to ensure their organs remain healthy, and experts and advocates fear a lack of adequate testing will lead to more failed organs.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More